Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.

Scope of the Report:
This report focuses on the Postmenopausal Vaginal Atrophy Treatment in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
Allergan
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.

Market Segment by Countries, covering
Germany
UK
France
Russia
Italy

Market Segment by Type, covers
Creams
Tablets
Patches
Rings

Market Segment by Applications, can be divided into
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy

There are 17 Chapters to deeply display the Europe Postmenopausal Vaginal Atrophy Treatment market.

Chapter 1, to describe Postmenopausal Vaginal Atrophy Treatment Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Postmenopausal Vaginal Atrophy Treatment, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Postmenopausal Vaginal Atrophy Treatment, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;

Chapter 12, Postmenopausal Vaginal Atrophy Treatment market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe Postmenopausal Vaginal Atrophy Treatment sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Postmenopausal Vaginal Atrophy Treatment Research Findings and Conclusion, Appendix, methodology and data source